⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3474302 | 0.96 | — | — | |
| SCHEMBL8741717 | 0.91 | — | — | |
| SCHEMBL2153353 | 0.85 | — | — | |
| SCHEMBL9008981 | 0.83 | — | — | |
| SCHEMBL8744936 | 0.83 | — | — | |
| SCHEMBL859389 | 0.83 | — | — | |
| SCHEMBL610721 | 0.79 | — | — | |
| Di(Hydroxyethyl)Ether SCHEMBL3474303 | 0.79 | — | — | |
| Ethylene Glycol SCHEMBL4563857 | 0.79 | — | — | |
| Ethylene Glycol SCHEMBL243462 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 549 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12344635-B2 | COVID-19 vaccine | THE MEDICAL COLLEGE OF WISCONSIN, INC. (US) | 2025-07-01 | — | — | US | claimed |
| EP-4103585-A1 | PEPTIDES TARGETING MACROPHAGES, AND CONJUGATES, COMPOSITIONS, AND USES THEREOF | Twinpig Biolab, Inc. (KR) | 2022-12-21 | — | — | EP | claimed |
| WO-2022234346-A1 | PEPTIDES TARGETING MACROPHAGES, AND CONJUGATES, COMPOSITIONS, AND USES THEREOF | TWINPIG BIOLAB, INC. (KR) | 2022-11-10 | — | — | WO | claimed |
| US-20220354957-A1 | PEPTIDES TARGETING MACROPHAGES, AND CONJUGATES, COMPOSITIONS, AND USES THEREOF | TWINPIG BIOLAB, INC. (KR) | 2022-11-10 | — | — | US | claimed |
| US-11484601-B2 | Targeting M2-like tumor-associated macrophages by using melittin-based proapoptotic peptide | TWINPIGBIOLAB INC. (KR) | 2022-11-01 | — | — | US | claimed |
| US-20210300970-A1 | COVID-19 VACCINE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-09-30 | — | — | US | claimed |
| US-20210244823-A1 | TARGETING M2-LIKE TUMOR-ASSOCIATED MACROPHAGES BY USING MELITTIN-BASED PROAPOPTOTIC PEPTIDE | TWINPIGBIOLAB INC. (KR) | 2021-08-12 | — | — | US | claimed |
| EP-3789041-A1 | TARGETING M2-LIKE TUMOR-ASSOCIATED MACROPHAGES BY USING MELITTIN-BASED PRO-APOPTOTIC PEPTIDE | Twinpigbiolab Inc. (KR) | 2021-03-10 | — | — | EP | claimed |
| US-10605810-B2 | Pincers comprising antibody and aptamer conjugated via a linker which binds to the same target material and use thereof | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2020-03-31 | — | — | US | claimed |
| US-20180263927-A1 | AFFINITY MEDICANT CONJUGATE | AF CHEMICALS, LLC (US) | 2018-09-20 | — | — | US | claimed |
| WO-2009131909-A2 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO-RAD LABORATORIES, INC. (US) | 2009-10-29 | — | — | WO | claimed |
| US-7604804-B2 | Two gp120 binding molecules that target the CD4 binding pocket on a trimeric HIV gp120 complex and gp120 binding molecules are separated by a spacer/linker of sufficient length to provide for binding of the gp120 binding molecules to the CD-4 binding sites on trimeric gp120 sites on virion surface | UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) | 2009-10-20 | — | — | US | claimed |
| WO-2009092383-A2 | PRODUCTS AND METHODS TO PREVENT INFECTION | MULTIMERICS APS (DK) | 2009-07-30 | — | — | WO | claimed |
| US-20080125365-A1 | ISOLATED COMPLEXES OF COVALENTLY CROSS-LINKED ENDOTOXIN AND MODIFIED MD-2 | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2008-05-29 | — | — | US | claimed |
| WO-2008036838-A2 | ISOLATED COMPLEXES OF COVALENTLY CROSS-LINKED ENDOTOXIN AND MODIFIED MD-2 | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2008-03-27 | — | — | WO | claimed |
| US-20070099225-A1 | Separation of chromosomes using an affinity-based magnetic bead separation in suspension | UNIVERSITY OF KANSAS | 2007-05-03 | — | — | US | claimed |
| US-20050176642-A1 | Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric GP120 | UNIVERSITY OF MARYLAND, BALTIMORE | 2005-08-11 | — | — | US | claimed |
| EP-0701448-B1 | AMPLIFICATION OF THE VITAMIN B 12 UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY LTD (AU) | 2002-08-14 | — | — | EP | claimed |
| WO-2001046461-A2 | MODIFIED NUCLEIC ACIDS AND THEIR USE | BIOCHIP TECHNOLOGIES GMBH (DE) | 2001-06-28 | — | — | WO | claimed |
| EP-1111069-A1 | Modified nucleic acids and their use | BioChip Technologies GmbH (DE) | 2001-06-27 | — | — | EP | claimed |